35010-98-1

Basic information

• Product Name: (S)-tert-butyl 2-(2-(((benzyloxy)carbonyl)amino)acetamido)-4-methylpentanoate
• Synonyms: (S)-tert-butyl 2-(2-(((benzyloxy)carbonyl)amino)acetamido)-4-methylpentanoate
• CAS NO: 35010-98-1
• Molecular Weight: 378.469
• Mol File: 35010-98-1.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (S)-tert-butyl 2-(2-(((benzyloxy)carbonyl)amino)acetamido)-4-methylpentanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-tert-butyl 2-(2-(((benzyloxy)carbonyl)amino)acetamido)-4-methylpentanoate(35010-98-1)
• EPA Substance Registry System: (S)-tert-butyl 2-(2-(((benzyloxy)carbonyl)amino)acetamido)-4-methylpentanoate(35010-98-1)

Safety Data

• Hazardous Substances Data: 35010-98-1(Hazardous Substances Data)

Upstream product

• 21691-53-2 L-leucine tert-butyl ester 
• 1138-80-3 N-(Benzyloxycarbonyl)glycine 
• 1212-53-9 methyl N-benzyloxycarbonylglycinate 
• 2748-02-9 L-leucine tert-butyl ester hydrochloride 
• 80682-32-2 tert-butyl leucinate hydrotosylate 

Downstream Products

• 80682-33-3 (S)-2-(2-Amino-acetylamino)-4-methyl-pentanoic acid tert-butyl ester; compound with toluene-4-sulfonic acid 

Relevant articles and documents

Stereocontrolled [11C]Alkylation of N-Terminal Glycine Schiff Bases To Obtain Dipeptides

The use of various quaternary ammonium salts as chiral phase-transfer catalysts allowed effective and stereoselective radiochemical [11C]alkylation to obtain functionalized dipeptides. We herein report a broadly applicable procedure for the asymmetric [11C]alkylation of dipeptides to give labeled N-terminal peptides by using different [11C]alkyl halides. Contended stereoselectivities of the reactions were observed by using 11C-labeled alkyl halides, [11C]methyl iodide and [11C]benzyl iodide, and diastereomeric ratios with different specialized catalysts of 95:5 and 90:10 were achieved, respectively. Accordingly, the straightforward synthesis of enantioenriched compounds should play a vital role in peptide-based radiopharmaceutical development and positron emission tomography imaging.

PEPTIDES-XXXXV. SYNTHESIS OF THE 118-129 FRAGMENT OF A LYSOZYME ANALOGUE

The synthesis of the (118-129) fragment of a Lysozyme analogue was achieved by the fragment coupling approach.The fragments were assembled using the DCCI/HONSu method and the (118-122), (123-126) and (127-129) subfragments were each built up in a stepwise

[8 Homoarginine]luteinizing hormone releasing hormone

The synthesis and LH releasing activity of [8 homoarginine] LH RH are described. Its biological activity is discussed in relation to that of other analogues with substitutions in position 8. Although in homoarginine the positive charge of the guanidino gr